ID MCF-7/S0.5 AC CVCL_1D47 SY MCF7/S0.5; MCF7 S0.5 DR cancercelllines; CVCL_1D47 DR CancerTools; 152090 DR ECACC; 16022501 DR Millipore; SCC100 DR Wikidata; Q54904379 DR Ximbio; 152090 RX PubMed=6362856; CC Population: Caucasian. CC Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line). CC Discontinued: ECACC; 16022501; true. CC Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. ST Source(s): ECACC=16022501; Millipore=SCC100 ST Amelogenin: X ST CSF1PO: 10 ST D13S317: 11 ST D16S539: 11,12 ST D18S51: 14 ST D21S11: 30 ST D3S1358: 16 ST D5S818: 11,12 ST D7S820: 9 ST D8S1179: 10,14 ST FGA: 23,25 ST Penta D: 12 ST Penta E: 7,12 ST TH01: 6 ST TPOX: 9,12 ST vWA: 14,15 DI NCIt; C4194; Invasive breast carcinoma of no special type OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0031 ! MCF-7 SX Female AG 69Y CA Cancer cell line DT Created: 08-07-15; Last updated: 19-12-24; Version: 20 CH CVCL_1D48 ! MCF-7/164R-1 CH CVCL_1D49 ! MCF-7/164R-4 CH CVCL_1D38 ! MCF-7/164R-5 CH CVCL_1D39 ! MCF-7/164R-7 CH CVCL_1D40 ! MCF-7/182R-1 CH CVCL_W536 ! MCF-7/182R-6 CH CVCL_1D41 ! MCF-7/182R-7 CH CVCL_5A09 ! MCF-7/AnaR-1 CH CVCL_5A10 ! MCF-7/AnaR-2 CH CVCL_5A11 ! MCF-7/AnaR-3 CH CVCL_5A12 ! MCF-7/AnaR-4 CH CVCL_5A13 ! MCF-7/ExeR-1 CH CVCL_5A14 ! MCF-7/ExeR-2 CH CVCL_5A15 ! MCF-7/ExeR-3 CH CVCL_5A16 ! MCF-7/ExeR-4 CH CVCL_5A17 ! MCF-7/LetR-1 CH CVCL_5A18 ! MCF-7/LetR-2 CH CVCL_5A19 ! MCF-7/LetR-3 CH CVCL_5A20 ! MCF-7/LetR-4 CH CVCL_M436 ! MCF-7/TAMR-1 CH CVCL_1D42 ! MCF-7/TAMR-4 CH CVCL_1D43 ! MCF-7/TAMR-7 CH CVCL_1D44 ! MCF-7/TAMR-8 // RX PubMed=6362856; RA Briand, Per RA Lykkesfeldt, Anne E. RT "Effect of estrogen and antiestrogen on the human breast cancer cell RT line MCF-7 adapted to growth at low serum concentration."; RL Cancer Res. 44:1114-1119(1984). //